CPSS vs GSK · P/E 11, rev $233.7M vs P/E 13, $103.31B cap
Consumer Portfolio Services Inc (CPSS) versus GlaxoSmithKline PLC ADR (GSK) — a side-by-side from cached financials, not a winner call.
Consumer Portfolio Services Inc (CPSS) is a credit services company listed on US.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Latest reported CPSS revenue for 2026-06-30 was $233.7M. Net income was $11.8M. CPSS currently screens at market cap $204.6M and trailing P/E 11.1.
GSK does not have a complete income-statement cache yet.
CPSS currently screens at market cap $204.6M and trailing P/E 11.1. GSK currently screens at market cap $103.31B and trailing P/E 13.5.
Not investment advice. Open the CPSS and GSK stock pages for the full models.
Not investment advice.